| Year |
Title |
Altmetric |
| 2018
|
Angiogenic and Osteogenic Synergy of Human Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells Cocultured on a Nanomatrix
2018
|
|
| 2018
|
Epigenetic remodeling and modification to preserve skeletogenesis in vivo
2018
|
|
| 2018
|
Specificity Protein 7 Is Required for Proliferation and Differentiation of Ameloblasts and Odontoblasts
2018
|
|
| 2017
|
Dwarfism in homozygous Agc1CreERT mice is associated with decreased expression of aggrecan
2017
|
|
| 2016
|
Transcriptional auto-regulation of RUNX1 P1 promoter
2016
|
|
| 2016
|
Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells
2016
|
|
| 2015
|
Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis
2015
|
|
| 2015
|
MicroRNA 665 regulates dentinogenesis through microRNA-mediated silencing and epigenetic mechanisms
2015
|
|
| 2015
|
Myeloma cell-derived Runx2 promotes myeloma progression in bone
2015
|
|
| 2014
|
Runx2 activity in committed osteoblasts is not essential for embryonic skeletogenesis
2014
|
|
| 2014
|
Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation
2014
|
|
| 2014
|
Sp7 and Runx2 molecular complex synergistically regulate expression of target genes
2014
|
|
| 2014
|
Specificity protein 7 is not essential for tooth morphogenesis
2014
|
|
| 2013
|
Breakpoint regions of ETO gene involved in (8; 21) leukemic translocations are enriched in acetylated histone H3
2013
|
|
| 2013
|
Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease
2013
|
|
| 2012
|
Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification
2012
|
|
| 2011
|
Biphasic peptide amphiphile nanomatrix embedded with hydroxyapatite nanoparticles for stimulated osteoinductive response
2011
|
|
| 2011
|
Effect of sodium hypochlorite on human pulp cells: An in vitro study
2011
|
|
| 2011
|
Chondrocyte-specific regulatory activity of Runx2 is essential for survival and skeletal development
2011
|
|
| 2011
|
Runx2 regulates the gene network associated with insulin signaling and energy homeostasis
2011
|
|
| 2011
|
Osteogenic differentiation of human mesenchymal stem cells synergistically enhanced by biomimetic peptide amphiphiles combined with conditioned medium
2011
|
|
| 2010
|
Subnuclear localization and intranuclear trafficking of transcription factors.
2010
|
|
| 2010
|
Genetic and Transcriptional Control of Bone Formation
2010
|
|
| 2010
|
Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation
2010
|
|
| 2010
|
Subnuclear localization and intranuclear trafficking of transcription factors
2010
|
|
| 2009
|
Identification of Potential Enhancers in the RUNX1 Gene
2009
|
|
| 2009
|
Altered chromatin modifications in AML1/RUNX1 breakpoint regions involved in (8;21) translocation
2009
|
|
| 2009
|
Transcription-factor-mediated epigenetic control of cell fate and lineage commitment
2009
|
|
| 2009
|
A Runx2 threshold for the cleidocranial dysplasia phenotype
2009
|
|
| 2009
|
Organization, integration, and assembly of genetic and epigenetic regulatory machinery in nuclear microenvironments: Implications for biological control in cancer
2009
|
|
| 2008
|
Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation
2008
|
|
| 2008
|
Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors
2008
|
|
| 2008
|
A Runx2 Threshold for the Cleidocranial Dysplasia Phenotype.
2008
|
|
| 2008
|
Induction of Runx2 and Osterix by Bisphosphonate Promote Osteogenic Differentiation
2008
|
|
| 2008
|
Genetic and epigenetic regulation in nuclear microenvironments for biological control in cancer
2008
|
|
| 2008
|
Chromatin immunoprecipitation assays: application of ChIP-on-chip for defining dynamic transcriptional mechanisms in bone cells.
2008
|
|
| 2008
|
In situ nuclear organization of regulatory machinery.
2008
|
|
| 2008
|
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling
2008
|
|
| 2008
|
Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal
2008
|
|
| 2008
|
Chromatin immunoprecipitation assays: Application of chip-on-chip for defining dynamic transcriptional mechanisms in bone cells
2008
|
|
| 2008
|
In situ nuclear organization of regulatory machinery
2008
|
|
| 2007
|
Growth inhibition of osteoblast progenitors by Runx2 depends on its C-terminal regulatory domain and is accompanied by changes in G-Protein coupled signaling pathways
2007
|
|
| 2007
|
Nuclear microenvironments in biological control and cancer
2007
|
|
| 2007
|
Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2
2007
|
|
| 2007
|
Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation
2007
|
|
| 2007
|
Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2
2007
|
|
| 2007
|
Organization of transcriptional regulatory machinery in nuclear microenvironments: Implications for biological control and cancer
2007
|
|
| 2006
|
BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network
2006
|
|
| 2006
|
BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network
2006
|
|
| 2006
|
Alterations in intranuclear localization of Runx2 affect biological activity
2006
|
|
| 2006
|
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone
2006
|
|
| 2006
|
Defects in intranuclear localization of Runx2 alter osteoblast differentiation ex vivo.
2006
|
|
| 2006
|
Mitotic retention of the bone phenotype by the cell fate determining transcription factor Runx2.
2006
|
|
| 2006
|
Post-mitotic expression of transcription factor RUNX2 defines a novel regulatory transition during the G1 phase of proliferating Pre-Osteoblasts.
2006
|
|
| 2006
|
Specific residues of Runx2/Cbfa1 direct Osteoblast differentiation and integration of BMP2 osteogenic signal.
2006
|
|
| 2006
|
Networks and hubs for the transcriptional control of osteoblastogenesis
2006
|
|
| 2006
|
Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2
2006
|
|
| 2006
|
Organization of transcriptional regulatory machinery in nuclear microenvironments: Implications for biological control and cancer
2006
|
|
| 2005
|
Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1
2005
|
|
| 2005
|
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion
2005
|
|
| 2005
|
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression
2005
|
|
| 2005
|
A critical point mutation in the Runx2 subnuclear targeting domain abrogates osteogenic function by blocking integration of the BMP2 signal
2005
|
|
| 2005
|
Msx2 antagonizes Runx2 regulation of osteolytic activity in breast cancer cells.
2005
|
|
| 2005
|
Organization of transcriptional regulatory machinery in osteoclast nuclei: Compartmentalization of Runx1
2005
|
|
| 2005
|
Reconstitution of Runx2/Cbfa1null cells identifies Runx2 domains required for osteoblast differentiation
2005
|
|
| 2005
|
Runx2 association with microtubules: A potential role in nucleo-cytoplasmic shuttling.
2005
|
|
| 2005
|
The Runx2 transcription factor supports expression of genes coupled to the invasive and osteolytic properties of breast cancer cells.
2005
|
|
| 2005
|
Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription
2005
|
|
| 2005
|
The dynamic organization of gene-regulatory machinery in nuclear microenvironments
2005
|
|
| 2005
|
SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation
2005
|
|
| 2005
|
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo
2005
|
|
| 2005
|
Combinatorial organization of the transcriptional regulatory machinery in biological control and cancer
2005
|
|
| 2005
|
Contributions of nuclear structure-function relationships to the onset and progression of tumorigenesis
2005
|
|
| 2005
|
Runx2 regulates tumor cell invasive properties and contributes to the osteolytic bone disease associated with metastatic cancer cells
2005
|
|
| 2005
|
Runx2/Msx2 interactions regulating breast cancer-induced osteolysis in bone
2005
|
|
| 2004
|
Nuclear microenvironments support assembly and organization of the transcriptional regulatory machinery for cell proliferation and differentiation
2004
|
|
| 2004
|
Active retention of phenotype during cell division: Runx (AML/Cbfa) transcription factors are bound to gene promoters within the condensed mitotic chromosomes
2004
|
|
| 2004
|
Intranuclear trafficking: Organization and assembly of regulatory machinery for combinatorial biological control
2004
|
|
| 2004
|
The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain
2004
|
|
| 2004
|
Convergence of BMP2/TGF beta MAPK and Runx2 signaling in subnuclear foci during osteogenic lineage induction
2004
|
|
| 2004
|
Dlx3 is a transcriptional regulator of osteoblast differentiation and increases expression and promoter activity of Runx2.
2004
|
|
| 2004
|
Dlx3 transcriptional regulation of osteoblast differentiation: Temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene
2004
|
|
| 2004
|
Establishment of a mechanistic link between the osteogenic function of Runx2 and its sulnuclear organization by intranuclear informatics.
2004
|
|
| 2004
|
Expression pattern of core binding factor-beta in skeletal tissues
2004
|
|
| 2004
|
Multiple nuclei in osteoclasts functionally compartmentalize gene regulatory machinery
2004
|
|
| 2004
|
Quantitative signature for architectural organization of regulatory factors using intranuclear informatics
2004
|
|
| 2004
|
Wnt signaling regulates Runx2 expression in vivo and activates the bone-related Runx2 P1 promoter
2004
|
|
| 2004
|
Ectopic Runx2 regulates breast cancer metastasis-associated osteolytic disease
2004
|
|
| 2004
|
Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease
2004
|
|
| 2004
|
Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression
2004
|
|
| 2004
|
Regulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML Factors
2004
|
|
| 2004
|
Nuclear microenvironments: An architectural platform for the convergence and integration of transcriptional regulatory signals
2004
|
|
| 2004
|
Analysis of in vivo gene expression using epitope-tagged proteins.
2004
|
|
| 2004
|
Chromatin immunoprecipitation.
2004
|
|
| 2004
|
Immunofluorescence analysis using epitope-tagged proteins: in vitro system.
2004
|
|
| 2004
|
In situ immunofluorescence analysis: analyzing RNA synthesis by 5-bromouridine-5'-triphosphate labeling.
2004
|
|
| 2004
|
In situ immunofluorescence analysis: immunofluorescence microscopy.
2004
|
|
| 2004
|
PLURIPOTENCY OF ADULT STEM CELLS: INSTRUCTIONS FOR OSTEOGENIC LINEAGE DIRECTION
2004
|
|
| 2004
|
Protein-deoxyribonucleic acid interactions linked to gene expression: DNase I digestion.
2004
|
|
| 2004
|
Protein-deoxyribonucleic acid interactions linked to gene expression: electrophoretic mobility shift assay.
2004
|
|
| 2004
|
Protein-deoxyribonucleic acid interactions linked to gene expression: ligation-mediated polymerase chain reaction.
2004
|
|
| 2003
|
Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells
2003
|
|
| 2003
|
Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells
2003
|
|
| 2003
|
Nuclear microenvironments support physiological control of gene expression
2003
|
|
| 2003
|
Chromatin remodeling of the proximal rat osteocalcin promoter is dependent on vitamin D receptor binding at the distal promoter element
2003
|
|
| 2003
|
Ectopic runx2 regulates breast cancer metastasis associated osteolytic disease
2003
|
|
| 2003
|
Subnuclear targeting supports functional interrelationships between Runx2 and the BMP-2 regulated Smad 1 protein
2003
|
|
| 2003
|
Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo
2003
|
|
| 2003
|
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells
2003
|
|
| 2003
|
Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity
2003
|
|
| 2003
|
Runx2/Cbfa1 functions: Diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions
2003
|
|
| 2003
|
Intranuclear trafficking of transcription factors: Requirements for vitamin D-mediated biological control of gene expression
2003
|
|
| 2003
|
Functional architecture of the nucleus: Organizing the regulatory machinery for gene expression, replication and repair
2003
|
|
| 2003
|
Intranuclear organization of RUNX transcriptional regulatory machinery in biological control of skeletogenesis and cancer
2003
|
|
| 2002
|
Cbfβ interacts with RUNX2 and has a critical role in bone development
2002
|
|
| 2002
|
Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains
2002
|
|
| 2002
|
Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains
2002
|
|
| 2002
|
Cbfb, a well-known, regulator of hematopoiesis, cooperates with Cbfa1 and plays a critical role in bone development.
2002
|
|
| 2002
|
Runx factors are expressed in the osteoclast and regulated during osteoclast differentiation.
2002
|
|
| 2002
|
Runx1(Cbfa2/AML1) is expressed in tissues supporting osteogenesis and temporally regulated during chondrocyte and osteoblast differentiation.
2002
|
|
| 2002
|
CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression
2002
|
|
| 2001
|
Runx2-C/EBP molecular interactions and functional synergism support maximal expression of osteocalcin in osteoblasts
2001
|
|
| 2001
|
Trafficking of Runx1/Cbfa2 and Runx2/Cbfa1 in living cells defines a dynamic subnuclear domain
2001
|
|
| 2001
|
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene
2001
|
|
| 2001
|
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene.
2001
|
|
| 2001
|
Developmental utilization of distinct promoters regulating the type I and type II isoforms of the bone Runx2/Cbfa1 transcription factor.
2001
|
|
| 2001
|
Differential Regulation of the Two Principal Runx2/Cbfa1 N-Terminal Isoforms in Response to Bone Morphogenetic Protein-2 during Development of the Osteoblast Phenotype
2001
|
|
| 2001
|
Forced expression of Runx2/Cbfa1 driven by the -3.6 kb Collagen Type I promoter results in a normal phenotype in transgenic mice.
2001
|
|
| 2001
|
Runx2-C/EBP molecular interactions and functional synergism support maximal expression of osteocalcin in osteoblasts.
2001
|
|
| 2001
|
Trafficking of Runx1/Cbfa2 and Runx2/Cbfa1 in living cells defines a dynamic subnuclear domain.
2001
|
|
| 2001
|
Subnuclear targeting of Runx/CBFa/AML factors is essential for tissue-specific differentiation during embryonic development
2001
|
|
| 2001
|
Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene
2001
|
|
| 2001
|
Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins
2001
|
|
| 2001
|
Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype
2001
|
|
| 2000
|
Expression and regulation of RUNX2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts
2000
|
|
| 2000
|
Intranuclear trafficking of RUNX2/Cbfa1 and RUNX1/AML1 in living cells
2000
|
|
| 2000
|
Nuclear matrix proteins as cancer markers
2000
|
|
| 2000
|
C/EBP is a potent activator of osteocalcin gene transcription.
2000
|
|
| 2000
|
In vivo replacement of the Runx2/Cbfa1 gene with a mutant gene lacking a subnuclear targeting signal and transcriptional regulatory functions results in severe skeletal abnormalities.
2000
|
|
| 2000
|
RUNX (CBFalpha/AML/PEBP2alpha) dependent repression of tissue-specific gene transcription involves in situ association with Groucho/TLE/R-esp proteins.
2000
|
|
| 2000
|
Intranuclear trafficking of transcription factors: Implications for biological control
2000
|
|
| 2000
|
Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies.
2000
|
|
| 2000
|
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBFα/AML/PEBP2α) dependent activation of tissue-specific gene transcription
2000
|
|
| 2000
|
Subnuclear organization and trafficking of regulatory proteins: implications for biological control and cancer.
2000
|
|
| 1999
|
The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A
1999
|
|
| 1999
|
Insight into regulatory factor targeting to transcriptionally active subnuclear sites
1999
|
|
| 1999
|
Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2αB/core binding factor α2
1999
|
|
| 1999
|
Contributions of chromatin structure to bone tissue-specific transcription.
1999
|
|
| 1999
|
Structure-function determinants for subnuclear targeting nod transactivation in the Cbfa1/AML3 transcription factor.
1999
|
|
| 1999
|
C/EBP family members are expressed in osteoblast and are involved in regulation of osteocalcin gene transcription.
1999
|
|
| 1999
|
Cbfa family members act as a negative regulator of the bone sialoprotein gene.
1999
|
|
| 1999
|
Contributions of nuclear architecture to bone-specific and steroid hormone regulation of osteocalcin gene transcription.
1999
|
|
| 1999
|
Structure-function determinants for subnuclear targeting and transactivation in the Cbfa1/AML3 transcription factor.
1999
|
|
| 1999
|
The C-terminus of CBFA1 supports subnuclear trafficking of green fluorescent protein tagged-CBFA1.
1999
|
|
| 1999
|
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation
1999
|
|
| 1999
|
Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization
1999
|
|
| 1998
|
CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation
1998
|
|
